Á. Pinto Marín

Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain

E. Gallardo, I. Durán, C. Camps, 2021, Clinical and Translational Oncology.

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

A. González del Alba, S. Vázquez Estévez, I. Chirivella González, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.

M. González Barón, Á. Pinto Marín, C. Gómez Raposo, 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[Superior vena cava syndrome].

M. González Barón, Á. Pinto Marín, 2009, Medicina clinica.

Pancreatic glucagonoma presenting as a pulmonary mass

J. Feliu, E. Hernández Agudo, M. González Barón, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Adjuvant hormonal therapy in perimenopausal patients

Á. Pinto Marín, Ana Isabel Ballesteros García, Yann Izarzugaza Perón, 2011, Advances in therapy.

mTOR pathway inhibition in renal cell carcinoma.

P. Auñón, M. Barón, E. E. Arranz, 2012, Urologic oncology.

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

A. González del Alba, S. Vázquez Estévez, I. Chirivella González, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.